Matthew John Meyer
8Patents
3h-index
24Co-inventors
49Inventor score
Filing activity: Mar 11, 2014 → Mar 3, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9415118B2 | Antibody drug conjugates | Chemistry; Metallurgy | 6 | Active |
| US9498532B2 | Antibody drug conjugates | Chemistry; Metallurgy | 5 | Active |
| US10238748B2 | Anti-CDH6 antibody drug conjugates | Physics | 4 | Active |
| US9982045B2 | Anti-CDH6 antibody drug conjugates | Physics | 3 | Active |
| US10973829B2 | Therapeutic uses of a C-RAF inhibitor | Human Necessities | 3 | Active |
| US10786578B2 | CKIT antibody drug conjugates | Chemistry; Metallurgy | 2 | Active |
| US12011449B2 | Therapeutic combinations comprising a c-RAF inhibitor | Human Necessities | 1 | Active |
| US11833215B2 | CKIT antibody drug conjugates | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.